Edition:
India

Adcock Ingram Holdings Ltd (AIPJ.J)

AIPJ.J on Johannesburg Stock Exchange

5,200.00ZAc
17 Jan 2020
Change (% chg)

39.00 (+0.76%)
Prev Close
5,161.00
Open
5,299.00
Day's High
5,299.00
Day's Low
5,140.00
Volume
578,150
Avg. Vol
301,647
52-wk High
6,912.00
52-wk Low
5,020.00

Summary

Name Age Since Current Position

Lindsay Ralphs

64 2019 Non-Executive Chairman of the Board

Andrew Hall

57 2015 Chief Executive Officer, Executive Director

Dorette Neethling

45 2016 Chief Financial Officer, Executive Director

Ntando Simelane

2011 Head of Legal, Company Secretary

Ashley Pearce

2014 Managing Director – Prescription

Sudier Ramparsad

Managing Director - Over the Counter

Colin Sheen

2014 Managing Director - Hospital

Gail Solomon

Managing Director – Consumer

Basadi Letsoalo

56 2016 Executive Director - Human Capital and Transformation

Jasvanti Bhana

Medical Director

Frans Cronje

2019 Operations and IT Executive

Tobie Krige

2019 Distribution Executive

Tim Walter

Mergers and Acquisitions Executive

Mattias Haus

70 2019 Lead Non-Executive Independent Director

Nompumelelo Madisa

40 2017 Non-Independent Non-Executive Director

Kevin Wakeford

59 2019 Non-Independent Non-Executive Director

Lulama Boyce

40 2017 Non-Executive Independent Director

Sibongile Gumbi

47 2019 Non-Executive Independent Director

Claudia Manning

52 2018 Non-Executive Independent Director

Anna Mokgokong

62 2018 Non-Executive Independent Director

Debra Ransby

46 2019 Non-Executive Independent Director

Kavitha Singh

2019 Corporate Communications Manager

Biographies

Name Description

Lindsay Ralphs

Mr. Lindsay Peter Ralphs has been appointed as Non-Executive Chairman of the Board of the Company., effective July 1, 2019. He currently serves as Non-Independent Non-Executive Director of the Company. He is the Director of various Bidvest’s subsidiaries. Mr Ralphs completed his studies at the University of the Witwatersrand graduating with a BCom degree and a BAcc degree. He qualified as a chartered accountant in 1981. He was appointed a Director of the Bidvest Group Limited in May 1992. He is a Director of numerous Bidvest subsidiaries, Chairman of the Bidvest South Africa divisions and Chairman of Bidvest Namibia. During his Bidvest career he has been Group Operations Director, Managing Director of Bidvest Steiner and was responsible for forming the Bidvest Services division in 1994. In February 2011, Mr Ralphs was appointed as CEO of Bidvest South Africa and in May 2016 was appointed CEO of The Bidvest Group Limited after the unbundling of The Bidvest Food Division (BidCorp).

Andrew Hall

Mr. Andrew G. Hall is an Chief Executive Officer, Executive Director of Adcock Ingram Holdings Ltd. Mr. Hall joined Adcock Ingram in October 2007 as the chief financial officer from his previous position as chief fi nancial officer of another listed pharmaceutical company in South Africa. Prior to that, Andy was the partner in charge of health sciences at Ernst & Young where he spent 13 years. Before joining Ernst & Young he was involved in retail pharmacy for two years and in sales and marketing with Pfizer for five years.

Dorette Neethling

Ms. Dorette Neethling is Chief Financial Officer, Executive Director of Adcock Ingram Holdings Ltd., Ms. Neethling, a qualified CA(SA) with a Master's degree in Commerce (Taxation), joined Adcock Ingram in August 2007 as the Group Financial Manager. She was previously Financial Director of Quintiles South Africa and a Financial Manager in the FMCG environment in Namibia. Ms Neethling also serves as a member of the Financial Reporting Investigation Panel of the Johannesburg Stock Exchange.

Ntando Simelane

Mr. Ntando E. Simelane serves as Head of Legal, Company Secretary of the Company. He joined Adcock Ingram in April 2009 as the Group’s Legal and Compliance Manager Appointed as Company Secretary on 1 April 2011 Spent nine years at the SABC in various legal Spent four years at the Advertising Standards Authority of SA (ASA) as a dispute resolution consultant.

Ashley Pearce

Mr. Ashley Pearce serves as Managing Director – Prescription of the Company. He Joined Adcock Ingram in October 2012 as Customer Relationship Executive Appointed into current role on 1 April 2013 Previously CEO of MSD in South Africa Over 28 years’ experience within the pharmaceutical industry, in Production, R&D, Business Development, and Sales and Marketing Has led both the Pharmaceutical Industry Association of South Africa (PIASA) and the Pharmaceutical Task Group (PTG).

Sudier Ramparsad

Colin Sheen

Mr. Colin Sheen serves as Managing Director - Hospital of the Company. He joined Adcock Ingram in June 2008 Previously held various roles at Schering- Plough including Divisional Director, Marketing Director and Head of the South African commercial business Spent 10 years at 3M Corporation in various commercial roles including Commercial Head of Pharmaceuticals.

Gail Solomon

Basadi Letsoalo

Ms. Basadi Letsoalo serves as Executive Director - Human Capital and Transformation of the Company. She is Responsible for human capital and strategy implementation including transformation. Joined Adcock Ingram in January 2008 as Group Human Capital Executive. She is a non-executive Director at NMG Consultants and Actuaries; and Ad-Izinyosi Proprietary Limited. She is also a member of the University of KwaZulu-Natal Council and a Trustee of Mpho ea Bophelo.

Jasvanti Bhana

Frans Cronje

Mr. Frans Cronje serves as Operations and IT Executive of the Company. He Joined Adcock Ingram in December 2007 Previously held a variety of IT executive roles at Tiger Brands over a period of 10 years Worked for an International IT company as an Applications Consulting and Project Manager More than 25 years IT experience in a variety of industries.

Tobie Krige

Mr. Tobie Krige serves as Distribution Executive of the Company. He joined Adcock Ingram in January 2012 More than 15 years’ experience in supply chain and logistics Worked in extended geographical areas in Europe, Middle East and Africa Worked for various other organisations, including Nampak and DHL.

Tim Walter

Mattias Haus

Prof. Mattias Haus. M.D.. has been appointed as Lead Non-Executive Independent Director of the Company., effective 01 July 2019. He currently serves as Non-Executive Independent Director of Adcock Ingram Holdings Limited., since from 01 June 2012. After graduating from the University of Cape Town in 1974, Professor Haus spent seven years in private general practice and five years in Paediatrics at the Red Cross War Memorial Children's Hospital, during which time he obtained a research doctorate (M.D.) from the University of Cape Town (UCT). He holds two post-graduate Diplomas from the Colleges of Medicine of South Africa in Paediatrics, and Obstetrics and Gynaecology, and is a Fellow of both the Royal College of Physicians (UK) and the College's of Medicine of South Africa. In 2004, he was seconded to the People's Republic of China as Vice President for Research and Development for AstraZeneca, China. Apart from his academic career, Professor Haus has been active in many areas of Commerce, Industry and the Financial Services Sector. He was a non-executive Director of the Professional Provident Society for ten years, Deputy Chairman of the PPS Holding Company, and Chairman of both the PPS Holding Company and PPS Insurance Company. He is past Chairman of the Allergy Society of South Africa, a Director and Trustee of various other companies, was appointed Adjunct Professor (Faculty of Health Sciences, UCT) in 2000, and served on a World Health Organisation Task Force compiling guidelines for the Prevention of Asthma and Allergic Diseases.

Nompumelelo Madisa

Ms. Nompumelelo Thembekile Madisa serves as Non-Independent Non-Executive Director of the Company. Ms Madisa is a business executive with a Master’s Degree in Finance and Investment from the University of the Witwatersrand. She is an Executive Director at the Bidvest Group Limited and a member of various of its Board Committees. Ms Madisa is also a Director of numerous Bidvest subsidiaries. She has held various senior positions within the Bidvest Group of companies since 2008 and also has experience in the public sector.

Kevin Wakeford

Mr. Kevin Wakeford serves as Non-Independent Non-Executive Director of the Company. He was Chief Executive Officer of the Company. Mr. Wakeford joins Adcock Ingram following more than 10 years' experience with The Bidvest Group Limited, where he led various companies within the group. He served as Chief Executive Officer of Bidvest Travel and Aviation for the past three years. Prior to joining Bidvest, he spent nine years in the Southern Sun Hotel group and prior to that he was Group Financial Manager at SA Breweries. Kevin is a Chartered Accountant (SA) and was educated at the University of Cape Town after which he served articles at Arthur Young.

Lulama Boyce

Ms. Lulama Boyce serves as Non-Executive Independent Director of the Company. Ms Boyce is Head of Department for commercial accounting in the school of accounting at the University of Johannesburg. She is also a non-executive Director at Coronation Fund Managers Limited, Coronation Management Company (RF) Proprietary Limited and Coronation Life Assurance Company Limited. She was Financial and consulting experience in both the private and public sectors and Account manager of the Industrial Development Corporation and Senior lecturer and subject head in commercial accounting department at UJ.

Sibongile Gumbi

Dr. Sibongile Gumbi Ph.D. serves as Non-Executive Independent Director of the Company.D serves as Non-Executive Independent Director of the Company. serves as Non-Executive Independent Director of the Company. Dr Gumbi is the Founder and CEO of iVacBio, a company involved in the manufacture of animal health products. She holds a PhD in Pharmacology from the University of Cape Town and MBA from IMD, Switzerland. She is a Fellow of the eighth class of the African Leadership Initiative and a member of its associated Global Leadership Network. Sibongile is a specialist in technology and innovation management having worked in several leadership positions for local and international organisations concerned with science, technology and innovation.

Claudia Manning

Dr. Claudia Manning Ph.D. serves as Non-Executive Independent Director of the Company. Dr Manning is a business leader with a Doctorate in multi-disciplinary development studies at the University of Sussex in the United Kingdom and has experience across various fields, including at Development Bank of Southern Africa (DBSA) and Department of Trade and Industries (DTI). She is also a Non-Executive Director at Basil Read Holdings, Mondi Zimele Proprietary Limited, Sangena Investment Proprietary Limited and MSC Educational Holdings.

Anna Mokgokong

Dr. Anna Mokgokong is no longer serves as Non-Executive Independent Director of the Company effective 2/29/2020. She is the co-founder and executive chairperson of Community Investment Holdings (Pty) Ltd. Previous experience Deputy Chairperson for Community Oil and Gas Trading Independent non-executive director of Shoprite Holdings Non-Executive Chairperson of Rebosis Property Fund Ltd and Jasco Electronics Ltd. Serves on the boards of Afrocentric Ltd and Medscheme Ltd.

Debra Ransby

Ms. Debra Ransby serves as Non-Executive Independent Director of the Company. Ms Ransby is a qualified CA(SA) and a member of the Institute of Directors. Debbie previously worked in various functions at GlaxoSmithKline (GSK) including Finance, Supply Chain and Administration and led various cross-functional projects. She also worked as Finance Director at Takeda (formerly Nycomed) before serving as Managing Director. During her 11 years at Takeda, she managed the Finance function for Africa, and led various projects for the NEMEA (Near East, Middle East and Africa) region. Debbie is also a qualified executive business coach.

Kavitha Singh